The potential of metabolomics for Leishmania research in the post-genomics era.
about
Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmaniaFunctional genomics of trypanosomatidsMetabolomics to unveil and understand phenotypic diversity between pathogen populationsMetabolomic profiling of faecal extracts from Cryptosporidium parvum infection in experimental mouse modelsUsing a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotesA Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantumLC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case.Drug search for leishmaniasis: a virtual screening approach by grid computing.Exploring the metabolic state of microorganisms using metabolomics.Determination of antiprotozoal drug mechanisms by metabolomics approaches.Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review.Evaluating drug resistance in visceral leishmaniasis: the challenges.Metabolomics-Based Study of Logarithmic and Stationary Phases of Promastigotes in Leishmania major by 1H NMR Spectroscopy.Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania.Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.A complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine.Bayesian Approaches for Mass Spectrometry-Based Metabolomics
P2860
Q27009505-C599D43D-4DA8-4C21-8277-9A34C0BCC274Q27022024-471334E1-CF6A-461F-B539-2FBB1AA171BAQ28476399-9582E52C-95D9-45F1-B5EE-17C4C04EAF3BQ28534543-7EC35F7E-9933-4749-89A6-F8C030552313Q28542767-487C50F2-2E3F-45C8-A388-393028C4A8EEQ28546448-E4CC73EA-25D5-42E2-892E-1F8C153B1C5EQ30790484-80083176-9F30-4CF4-8F8B-E5B094223D53Q36082949-8B2B97C0-FF83-4770-9CA6-DB502B288C06Q37954705-E5F4432F-D3F6-4B91-B947-DE1424DD3B11Q38111816-C9880760-8156-4D4A-A7D7-EB98D923DCB7Q38533526-F2D7B306-16B7-4C67-808A-62EBB3A29B05Q39014583-7F1557F2-7E32-40B2-B415-5E96DB5F019AQ40291175-DB0F2E2F-F9CC-4896-A02F-1060FFBB3C24Q46907074-96EE2B8A-BC69-410A-8F63-999433BCDBC3Q46986733-19DFB001-C76F-4FE9-8F2B-C86184BF2E14Q49792065-82486904-72AB-45D1-82B9-D64B41743B62Q57016787-0B0D757F-DF0F-4A56-917C-BB2D8126AE1D
P2860
The potential of metabolomics for Leishmania research in the post-genomics era.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The potential of metabolomics for Leishmania research in the post-genomics era.
@en
The potential of metabolomics for Leishmania research in the post-genomics era.
@nl
type
label
The potential of metabolomics for Leishmania research in the post-genomics era.
@en
The potential of metabolomics for Leishmania research in the post-genomics era.
@nl
prefLabel
The potential of metabolomics for Leishmania research in the post-genomics era.
@en
The potential of metabolomics for Leishmania research in the post-genomics era.
@nl
P2093
P2860
P1433
P1476
The potential of metabolomics for Leishmania research in the post-genomics era.
@en
P2093
Graham H Coombs
Jean-Claude Dujardin
Richard A Scheltema
Ruben T'kindt
P2860
P304
P356
10.1017/S0031182009992022
P577
2010-01-29T00:00:00Z